<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01121874</url>
  </required_header>
  <id_info>
    <org_study_id>CMC-101</org_study_id>
    <nct_id>NCT01121874</nct_id>
  </id_info>
  <brief_title>Suture Fixation System Versus Tendonous Reconstruction in Carpometacarpal (CMC) Arthroplasty</brief_title>
  <official_title>Suture Fixation System Versus Tendonous Reconstruction in Thumb Carpometacarpal Arthroplasty: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>J&amp;M Shuler</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>J&amp;M Shuler</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thumb carpometacarpal (CMC) arthritis affect 1 in 4 females and 1 in 12 males. Patients who
      fail to respond to conservative treatment may benefit from surgery; however, controversy
      exists over the most effective surgical technique. A popular technique, ligament
      reconstruction with tendon interposition (LRTI) involves a trapeziectomy, followed by
      reconstruction of the palmar oblique ligament using a harvested flexor tendon from the wrist.

      We believe that use of a suture fixation system to reconstruct the palmar oblique ligament,
      instead of harvesting a wrist tendon, may provide a superior repair. The objective of this
      study is to compare functional outcome measurements among patients who receive CMC
      arthroplasty using a suture fixation system (investigational group) to those who receive LRTI
      surgery (control group). We hypothesize that patients in the investigational group will
      demonstrate superior functionality, compared to patients in the control group.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall functionality</measure>
    <time_frame>Baseline</time_frame>
    <description>Functionality will be assessed using the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire, which assesses functionality of the upper extremity, and Short Form 36 (SF-36) health outcomes assessment, which quantifies global functionality (not specific to the upper extremity).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Functionality</measure>
    <time_frame>6 wks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Functionality</measure>
    <time_frame>3 mos</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Functionality</measure>
    <time_frame>6 mos</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Functionality</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Functionality</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analog pain scale</measure>
    <time_frame>Baseline, 2 wks, 6 wks, 3 mos, 6 mos, 12 mos, 24 mos</time_frame>
    <description>Pain will be assessed using the visual analog pain scale, which asks the patient to rate their pain on a scale from 1 to 10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Strength measures</measure>
    <time_frame>Baseline, 6 wks, 3 mos, 6 mos, 12 mos, 24 mos</time_frame>
    <description>Strength will be assessed via key and tip pinch strength and grip strength, using a dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of motion</measure>
    <time_frame>Baseline, 6 wks, 3 mos, 6 mos, 12 mos, 24 mos</time_frame>
    <description>Range of motion (ROM) will be assessed via radial and palmar abduction (degrees) and opposition (cm).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>Baseline, 6 wks, 3 mos, 6 mos, 12 mos, 24 mos</time_frame>
    <description>Operative time in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scaphometacarpal distance</measure>
    <time_frame>Baseline, 6 wks, 3 mos, 6 mos, 12 mos, 24 mos</time_frame>
    <description>Distance between the distal pole of the scaphoid and the proximal aticular surface of the metacarpal. Taken in stressed and relaxed views</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Thumb Carpometacarpal Arthritis</condition>
  <arm_group>
    <arm_group_label>LRTI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>These patients will undergo ligament reconstruction with tendon interposition (LRTI) surgery. They will serve as a control group, against which to compare the investigational surgical technique.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Suture fixation system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CMC arthroplasty which reconstructs palmar oblique ligament using a suture fixation system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Suture fixation system + 2 week immobilization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CMC arthroplasty which reconstructs palmar oblique ligament using a suture fixation system, and with a decreased immobilization time from 6 to 2 weeks post-surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ligament reconstruction with suture fixation system</intervention_name>
    <description>CMC arthroplasty consisting of reconstruction of the palmar oblique ligament using a suture fixation system</description>
    <arm_group_label>Suture fixation system</arm_group_label>
    <other_name>Arthrex Mini TightRope</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ligament Reconstruction with Tendon Interposition (LRTI)</intervention_name>
    <description>commonly performed CMC arthroplasty technique, consisting of a trapeziectomy, followed by palmar oblique ligament reconstruction using a harvested flexor tendon from the wrist.</description>
    <arm_group_label>LRTI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ligament reconstruction with suture fixation system</intervention_name>
    <description>CMC arthroplasty consisting of reconstruction of the palmar oblique ligament using a suture fixation system, with a decreased period of immobilization from 6 weeks to 2 weeks.</description>
    <arm_group_label>Suture fixation system + 2 week immobilization</arm_group_label>
    <other_name>Arthrex Mini TightRope</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female patients aged &gt;18.

          -  Eaton Stage III or IV CMC arthritis

          -  Failure to respond to conservative treatment

        Exclusion Criteria:

          -  Previous surgical interventions on that thumb

          -  Upper extremity neurological dysfunction

          -  Inability to effectively communicate with the research staff, due to hearing
             impairment, cognitive impairment, or a language barrier

          -  Unwilling or unable to provide written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Shuler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Athens Orthopedic Clinic, PA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Athens Orthopedic Clinic</name>
      <address>
        <city>Athens</city>
        <state>Georgia</state>
        <zip>30606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2010</study_first_submitted>
  <study_first_submitted_qc>May 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2010</study_first_posted>
  <last_update_submitted>March 15, 2017</last_update_submitted>
  <last_update_submitted_qc>March 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>J&amp;M Shuler</investigator_affiliation>
    <investigator_full_name>Michael Shuler</investigator_full_name>
    <investigator_title>Hand and Upper Extremity Specialist</investigator_title>
  </responsible_party>
  <keyword>CMC arthritis</keyword>
  <keyword>thumb carpometacarpal arthritis</keyword>
  <keyword>basal joint arthritis</keyword>
  <keyword>thumb CMC arthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

